facebook pixel
Skip to Main Content
Boston University School of Law

  • Academics
  • Admissions & Aid
  • Faculty & Research
Search
  • Current Students
  • Faculty & Staff
  • Alumni
  • Employers
  • Journalists
Search
  • Academics
    • Academic Enrichment Program
    • Find Degrees and Programs
    • Explore Your Options
    • Study Abroad
    • Academic Calendar
  • Admissions & Aid
    • JD Admissions
    • Graduate Admissions
    • Tuition & Fees
    • Financial Aid
    • Visits & Tours
  • Faculty & Research
    • Faculty Profiles
    • Activities & Engagements
    • Centers & Institutes
    • Faculty Resources
  • Experiential Learning
    • Clinics & Practicums
    • Externship Programs
    • Simulation Courses
    • Law Journals
    • Moot Court
  • Careers & Professional Development
    • Judicial Clerkship Program
    • Career Advising for Graduate Students
    • Employment Statistics
    • Legal Career Paths
    • Public Service Programs
  • Student Life
    • Law Student Well-Being
    • Law Student Organizations
    • Boston Legal Landscape
  • Law Libraries
    • About the Libraries
    • A-Z Database List
    • Institutional Repository
  • About BU Law
    • Offices & Services
    • Meet the Dean
    • Diversity, Equity & Inclusion
    • Visit Campus
  • News & Stories
    • All Stories
    • Faculty in the News
    • Collections
    • Past Issues of The Record

Want to Support BU Law?Learn how you can give back


Latest Stories From The Record

Al-Johani-“Aljon”-Gandamato-photo-cropped
LLM in Banking and Financial Law

Banking on Boston

Read more
BU Law News

Former US Attorney General Loretta E. Lynch Is BU Law’s 2025 Commencement Speaker

Read more
BU Law News

BU Law Celebrates 2025 Retiring Faculty

Read more
Gender and Law

The Women of BU Law

Read more
Past

Evidence for Action (E4A) Dialogue on Antimicrobial Resistance

Valletta, Malta

Feb•6•24
—
Feb•7•24

Download the program

Evidence for Action (E4A) Dialogue on Antimicrobial Resistance

Jump To
  • Agenda
  • Resources
  • Speakers

The inaugural Evidence for Action (E4A) Dialogue on Antimicrobial Resistance (AMR) was hosted by Hon. Dr. Chris Fearne MP, Deputy Prime Minister of Malta, chaired by Professor Dame Sally Davies, UK Special Envoy on AMR, and moderated by Professor Kevin Outterson, Austin B. Fletcher Professor of Law at Boston University and Executive Director of CARB-X.

The objective of the conference was to identify the most pressing research questions from AMR champions in political and policy circles, and connect those questions with top-level researchers who will either point to existing data or trigger new research to fill the gaps. For this inaugural E4A Dialogue, the focus was on the most urgent research questions that can help mobilize political action to address the pipeline and access crisis of antibacterial products for human health.

Sponsors

Malta Sponsors

Agenda

  • Download the program

  • Mon., 5 February

  • 19:00 - 22:00

    Welcome Reception

    Welcome reception at The Embassy Valletta Hotel (directions)

  • Tue., 6 February

  • 8:00–9:00

    Registration

    Registration with light breakfast at The Valletta Campus (directions)

  • 9:00–9:10

    Welcome Speech

    Welcome speech by Professor Dame Sally Davies, Special Envoy on Antimicrobial Resistance, United Kingdom

  • 9:10–9:30

    Opening Remarks

    Opening remarks by Professor Kevin Outterson, Austin B. Fletcher Professor of Law at Boston University and Executive Director of CARB-X

  • 9:30–10:30

    Interviews with Ministers of Health and members of the Global Leaders Group

    Interviews with Ministers of Health and members of the Global Leaders Group about the importance of better evidence for stronger political action against AMR

  • 10:30–11:00

    Break

  • 11:00–12:45

    Session 1

    Better evidence for stronger political action against AMR

  • 12:45-14:00

    Lunch

  • 14:00–15:45

    Session 2

    Better evidence for stronger political action on push and pull incentives to stimulate innovation and facilitate access globally

  • 15:45–16:15

    Break

  • 16:15–18:00

    Session 3

    Better evidence for stronger political action on prioritizing access to new and existing antibacterial products in low- and middle-income countries

  • 18:30–21:00

    Networking Reception

    Networking reception at The Casino Maltese (directions)

  • Wed., 7 February

  • 8:30–9:30

    Light breakfast

    Light breakfast at The Valletta Campus (directions)

  • 9:30–11:15

    Session 4

    Better evidence for stronger political action on monitoring and accountability

  • 11:15–11:45

    Break

  • 11:45–12:30

    Session 5

    A conversation about 2024 with Dr. Christopher Fearne, Deputy Prime Minister and Minister for European Funds, Social Dialogue and Consumer Protection, Malta (co-facilitator of the United Nations General Assembly High-Level Meeting on AMR) and Rakan Bin Dohaish, Assistant Deputy Minister for International Collaborations, Ministry of Health, Saudi Arabia (host of 4th High-Level Ministerial Conference on AMR).

  • 12:30–13:00

    Concluding Remarks

    Concluding remarks by Dr. Christopher Fearne, Deputy Prime Minister and Minister for European Funds, Social Dialogue and Consumer Protection, Malta, Professor Dame Sally Davies, Special Envoy on Antimicrobial Resistance, United Kingdom, and Professor Kevin Outterson, Austin B. Fletcher Professor of Law at Boston University and Executive Director of CARB-X

  • 13:00–15:00

    Lunch

Resources

Location
The event took place at the Valletta Campus of the University of Malta (Google Map).

Map of meeting space
You can download a map of the first floor of the Valletta Campus here.

Photos
You can find the photos of the event at this link.

Speakers

The E4A Dialogue on AMR stood out by actively engaging each participant as a speaker, harnessing the collective expertise present. Distinct from conventional conferences, our format avoided panels and protracted monologues in favor of genuine dialogue among AMR policy leaders and preeminent researchers. The focus was on dynamic interaction, primarily through roundtable discussions. Regular rotation of tables ensured a vibrant exchange of insights.

Participants

List of Participants

  • André Abreu, Ministry of Health, Brazil
  • Caroline Agrell, Ministry of Health, Sweden
  • Sadim Alhayli, Ministry of Health, Saudi Arabia
  • Afreenish Amir, National Institute of Health, Pakistan
  • Martina Amito, Ministry of Water and Environment, Uganda
  • Peter Lawætz Andersen, Novo Nordisk Foundation
  • James Anderson, AMR Industry Alliance
  • Christine Årdal, Norwegian Institute of Public Health
  • Beatrice Atim Anywar, Minister of State for Environment, Uganda
  • Enrico Baraldi, Uppsala University
  • Hatice Beton, G20/G7 Health and Development Partnership
  • Peter Beyer, GARDP
  • Michael Borg, National Antibiotic Committee, Malta
  • Sergio Carmona, FIND
  • Pedro César, Ministry of Health, Portugal
  • Sujith Chandy, ICARS
  • Rena Conti, Boston University
  • Michael Corley, BSAC
  • Carlos Correa, South Centre
  • Antonio Correia de Campos, Former Minister of Health, Portugal
  • Thomas Cueni, IFPMA
  • Hebah Mahmoud Dada, Public Health Authority of Saudi Arabia
  • Sally Davies, UK Special Envoy on AMR
  • Maggie De Block, Former Minister of Health, Belgium
  • Damiano de Felice, CARB-X
  • Christoph Dehio, NCCR AntiResist
  • Rakan Bin Dohaish, Ministry of Health, Saudi Arabia
  • Christiane Dolecek, University of Oxford
  • Erin Duffy, CARB-X
  • Sabiha Essack, University of KwaZulu-Natal
  • Dimitri Eynikel, Médecins Sans Frontières
  • Chris Fearne, Deputy Prime Minister, Malta
  • Jakob Forssmed, Minister of Health, Sweden
  • Marc Gitzinger, BEAM Alliance
  • Malin Grape, AMR Ambassador, Sweden
  • Martha Gyansa-Lutterodt, Former Chief Pharmacist of the Ministry of Health, Ghana
  • Ralf Halfmann, Ministry of Health, Germany
  • Abigail Herron, Aviva Investors
  • Aidan Hollis, University of Calgary
  • Shalini Jayasekar-Zürn, Union for International Cancer Control
  • Tim Jinks, Wellcome Trust
  • Andrew Kambugu, University of Makerere
  • Maia-Triin Kanarbik, Ministry of Health, Estonia
  • Ilona Kickbusch, Charité, Berlin
  • Namubiru Saudah Kizito, Ministry of Health, Uganda
  • Elizabeth Klemm, Novo Nordisk Foundation
  • Keith Klugman, Bill & Melinda Gates Foundation
  • Jeremy Knox, Wellcome Trust
  • Ramanan Laxminarayan, One Health Trust
  • Danilo Lo Fo Wong, WHO Europe
  • Claudia Louati, European Patients’ Forum
  • Calman MacLennan, Jenner Institute
  • Michael Makanga, Global Health EDCTP3
  • Rebecca Manaley, Office of the UK Special Envoy on AMR
  • Laura Marin, JPIAMR
  • Anthony McDonnell, Center for Global Development
  • Marc Mendelson, University of Cape Town
  • Ren Minghui, Peking University
  • Angela Monahan, Department of Health and Human Services, United States
  • Judith Moore, World Economic Forum
  • Mari Viro Moser, Federal Office of Public Health, Switzerland
  • Mirfin Mpundu, ReAct Africa
  • Laurent Muschel, DG HERA, European Commission
  • Susan Nabadda, Uganda’s Commissioner for Laboratory Services
  • Mohsen Naghavi, Institute for Health Metrics and Evaluation
  • Lesley Ogilvie, Global AMR R&D Hub
  • Norio Ohmagari, Japan National Center for Global Health and Medicine
  • Tochi Okwor, Nigeria CDC
  • Damiet Onderstal, DG HERA, European Commission
  • Kevin Outterson, Boston University
  • Loyce Pace, Department of Health and Human Services, United States
  • Mark Pearson, OECD
  • Laura Plant, International Vaccine Institute
  • Lukas Reinieren, Ministry of Health, The Netherlands
  • David Ripin, CHAI
  • Flavia Rossi, University of São Paulo
  • Paul Schaper, MSD
  • Rhonda Sealey-Thomas, PAHO
  • Cecilia Shah, United Nations Foundation
  • Mike Sharland, St George’s University Hospitals NHS Foundation Trust
  • Yasu Shiozaki, Former Minister of Health, Japan
  • Riina Sikkut, Minister of Health, Estonia
  • Henry Skinner, AMR Action Fund
  • Boumediene Soufi, Medicines for Europe (Sandoz)
  • Ermira Tartari Bonnici, University of Malta
  • Margarida Tavares, Secretary of State for Health Promotion, Portugal
  • Karla van Rooijen, Ministry of Health, The Netherlands
  • Pol Vandenbroucke, Shionogi
  • Karen Vincenti, Ministry of Health, Malta
  • Carla Vizzotti, Former Minister of Health, Argentina
  • Kamini Walia, Indian Council of Medical Research
  • Sofia Wennerstrand, Ministry of Health, Sweden
  • Evelyn Wesangula, East Central and Southern Africa Health Community
  • Lothar Wieler, Hasso Plattner Institute
  • Marijke Wijnroks, The Global Fund
  • Mo Yin, National University Hospital of Singapore
  • Peter Zarb, Mater Dei Hospital, Malta
  • Jeannete Zurita, Pontificia Universidad Católica del Ecuador

Connect with law

  • Instagram
  • Twitter
  • Facebook
  • LinkedIn

How to engage with us on social media:

  • Follow @BU_Law and tag us in your stories and posts on all platforms
  • Post, like, and retweet content, using event hashtag and tagging speaker(s)
  • Share event information on social media
  • Send registration link to your networks

Evidence for Action (E4A) Dialogue on Antimicrobial Resistance

Posted 1 year ago

More about School of Law

Also See

  • ABA Required Disclosures
  • Licensing Disclosures
  • Statement of Nondiscrimination

Contact Us

  • JD Admissions
  • LLM & Graduate Admissions
  • Offices & Services
  • Faculty & Staff Directory
  • Instagram
  • Twitter
  • Facebook
  • LinkedIn
© 2025 Boston University. All rights reserved. www.bu.edu
  • Current Students
  • Faculty & Staff
  • Alumni
  • Employers
  • Journalists
Search
Boston University

Boston University School of Law
765 Commonwealth Avenue Boston, MA 02215

  • ©2025 Boston University
  • Privacy Statement
  • Accessibility
  • Digital Millennium Copyright Act (DMCA)